Medical Developments International Limited (ASX:MVP)

Market Cap	45.63M -25.7%
Revenue (ttm)	40.64M +6.8%
Net Income	-436.00K
EPS	-0.00
Shares Out	112.66M
PE Ratio	n/a
Forward PE	608.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,980
Open	0.4100
Previous Close	0.4050
Day's Range	0.4050 - 0.4100
52-Week Range	0.3650 - 0.7650
Beta	1.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About ASX:MVP

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow mete...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error